argenx stock pre-market at EUR 814.80: minus 0.02 percent
Published on 10/06/2026 at 07:55 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
argenx stock was at EUR 814.80 pre-market at 7:54 a.m. CEST on October 6, 2026, down 0.02 percent versus the EUR 815.00 prior close at Lang & Schwarz on October 5, 2026.
Pre-market price
The Lang & Schwarz indication stood at EUR 814.80 at 7:54 a.m. CEST. The further course from the Xetra open at 9:00 a.m. CET/CEST is shown by the continuously updated real-time quote of argenx stock.
Previous close
Lang & Schwarz recorded a prior close of EUR 815.00 on October 5, 2026. The current pre-market indication is therefore EUR 0.20 below that reference price.
Clinical data presented
In a September 29, 2026 release carried by Yahoo Finance, argenx SE said it would present clinical, long-term and real-world data for VYVGART at the 2026 AANEM Annual Meeting and the MGFA Scientific Session.
The release said an analysis of more than 1,100 U.S. patients with myasthenia gravis showed improvements in MG-ADL scores, steroid burden and exacerbation rates. It also reported that VYVGART Hytrulo reduced the relative risk of grip-strength deterioration in CIDP patients by 71.5 percent in a post hoc analysis.
